Soum_Roy_RadOnc Profile Banner
SOUMYAJIT ROY Profile
SOUMYAJIT ROY

@Soum_Roy_RadOnc

Followers
913
Following
13K
Media
87
Statuses
3K

Human #IMG #RadOnc #Researcher via @aiims_newdelhi @RushCancer resident. Editor @Advances_ASTRO MSc Biostat+Epidem @EdinburghUni #PCSM #Rstats enthusiast

Chicago, IL, USA
Joined February 2016
Don't wanna be here? Send us removal request.
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 year
Now @EUplatinum network meta-analysis.👉 ADT+ARPI+RT is superior relative to ADT+ARPI w/ modest ⬆️ in OS in low volume mHSPC. 👉 In de novo low volume mHSPC no significant difference in OS w/ ADT+RT vs ADT+ARPI after adjustment for docetaxel use.
9
27
67
@Soum_Roy_RadOnc
SOUMYAJIT ROY
7 days
Do better @united ! Please do better! Your 15 USD meal voucher does not matter. what matters is time which you can't pay me back!!!.
1
0
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
7 days
They suddenly discovered a hardware issue. We r still waiting. There's no honest & transparent communication. Amazing example of awful service. Akin to a situation where a patient is in OR & after anesthesia the team says "oh! we can't do the surgery, we have technical issues" 😂.
1
0
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
7 days
Just wanted to share another fascinating story about @united . Had a flight to board from CLE to IAD at 6:05 am. The flight was at the gate since last night. Nobody bothered to check anything during that interval. And then we boarded and were deplaned right at 6:05 am.
1
0
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
8 days
RT @d_golden: Check out the ROECSG update for July 2025 #RadOnc #MedEd -
0
1
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
12 days
RT @APCCC_Lugano: Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collabor….
0
68
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
12 days
0
3
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
12 days
RT @medicalwatchBC: Love Twitter but not the noise? Get practice changing updates from social media. Subscribe to our weekly newsletter an….
0
1
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
13 days
RT @PaulSargos: ✨ JUST OUT in EUO,. New paper challenging a dogma. ⏩ MUST READ:.@ConstanceHuck has done a great job to show that CIS is no….
0
26
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
23 days
RT @Davicioni: Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000….
0
3
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
29 days
Tweet media one
0
22
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
RT @lauren_henke: That’s my bestie/partner-in-crime! Way to go @angela_jia_ 🥳 Killing it as usual.
0
3
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
RT @chavarriagaj: #ASCO25 | Dr. Ong on PSA kinetics in mHSPC (IRONMAN registry):.🧬 Real-world ADT+ARPI-treated pts (n≈4,586).📊 PSA at 6–12….
0
7
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
RT @EdwinPosadasMD: nice job by @MichaelOng_MD promoting the need to support TRIPLE-SWTICH… let’s see if acting on this PSA threshold is im….
0
2
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
Two slides from #ASCO2025 prostate oral session today. What's wrong with them? I will leave the further discussion to folks who are constantly teaching me @5_utr @PavlosMsaouel @yilun_sun @amit_chowdhry
Tweet media one
Tweet media two
0
1
4
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
RT @neerajaiims: Congrats @MichaelOng_MD for the stellar talk @ASCO #ASCO25 👉 PSA response (<0.2 ng/ml) after starting ADT+ARPI in mHSPC #p….
0
29
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
RT @neerajaiims: As shown by @MichaelOng_MD @ASCO #asco25 👉 treatment escalation (@SWOG Triple Switch/CCTG, and de-escalation trials have b….
0
15
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
RT @JasonBrownMDPhD: Our own @angela_jia_ presenting her excellent insights into prostate cancer abstracts #ASCO25 @UHhospitals @caseccc ht….
0
3
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
So poised discussion by Dr. Jia @angela_jia_.
@DrSpratticus
Daniel E Spratt
1 month
Proud Chair moment. The incredible @angela_jia_ representing @RadOncUH on the big stage of #asco25 as the discussant to two big hitting presentations @ASCO . Thoughtful analysis of benefit (or not of) intraprostatic immune modulating viral therapy and the role of MMAI in
Tweet media one
Tweet media two
0
3
13
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
RT @nsayeghmd: 👉🏻 Superstar @ziremozay presenting @ASCO our real-world data showing lutetium has better survival outcomes than cabazitaxel….
0
24
0
@Soum_Roy_RadOnc
SOUMYAJIT ROY
1 month
RT @neerajaiims: Just in from @ASCO #ASCO25 👉📢 Finally a T-cell engager in #prostatecancer mCRPC with minimal CRS syndrome (only grade 1, a….
0
42
0